| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 590.52B | 551.88B | 521.40B | 492.23B | 489.09B | 469.92B |
| Gross Profit | 138.63B | 124.02B | 118.27B | 114.09B | 119.49B | 111.75B |
| EBITDA | 72.43B | 63.50B | 59.94B | 56.73B | 61.10B | 54.36B |
| Net Income | 33.62B | 27.11B | 26.63B | 23.23B | 28.23B | 24.25B |
Balance Sheet | ||||||
| Total Assets | 612.00B | 572.40B | 571.46B | 520.99B | 492.45B | 485.46B |
| Cash, Cash Equivalents and Short-Term Investments | 175.02B | 150.68B | 151.23B | 143.65B | 148.50B | 144.25B |
| Total Debt | 37.49B | 54.74B | 50.58B | 53.83B | 54.26B | 69.98B |
| Total Liabilities | 219.87B | 196.40B | 193.70B | 186.91B | 174.38B | 190.05B |
| Stockholders Equity | 351.79B | 338.43B | 344.10B | 305.07B | 290.71B | 268.49B |
Cash Flow | ||||||
| Free Cash Flow | 32.02B | 30.28B | 33.37B | 23.32B | 35.53B | 34.69B |
| Operating Cash Flow | 50.20B | 45.13B | 47.79B | 38.48B | 48.64B | 46.63B |
| Investing Cash Flow | -20.82B | -15.55B | -16.48B | -24.82B | -14.09B | -38.45B |
| Financing Cash Flow | -21.98B | -36.31B | -21.94B | -19.38B | -18.18B | -12.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥44.28B | 21.44 | ― | 1.95% | 9.05% | 14.38% | |
76 Outperform | ¥259.91B | 14.78 | ― | 2.42% | 9.55% | 9.52% | |
73 Outperform | ¥2.62T | 19.24 | 8.35% | 1.77% | 5.39% | 4.89% | |
66 Neutral | ¥9.90B | 24.07 | ― | ― | 5.80% | -43.56% | |
64 Neutral | ¥632.92B | 16.50 | ― | 2.14% | 7.73% | 30.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥4.41B | 6.80 | ― | 3.03% | 6.87% | -1.10% |